Critical Care

Piramal Critical Care (PCC), a business division of Piramal Pharma Limited (PPL) is one of the leaders in inhaled anesthetics and a global player in hospital generics. PCC is motivated by its vision of commitment to delivering critical care solutions for patients and healthcare providers across the globe, while achieving sustainable and profitable growth for all the stakeholders.

To learn more about Piramal Critical Care, click here

PCC maintains a wide presence across the USA, Europe and more than 100 countries across the globe. Its rich product portfolio includes Inhalation Anesthetics such as Sevoflurane and Isoflurane, as well as Intrathecal Baclofen therapy, for spasticity management. PCC has wholly owned, state-of- the-art manufacturing facilities in the US and India that have successfully cleared periodical inspections by the US FDA, UK MHRA, and other regulators.

Its core strength lies in a highly qualified global workforce of more than 400 employees across 16 countries. PCC is focused on further expanding its global footprint through new product additions in the critical care space.

Committed to corporate social responsibility alongside Piramal Group, PCC collaborates with various partner organizations and proudly takes an active role in providing hope and resources to those in need, as well as caring for the environment.